Cleared Traditional

K771953 - GASTRIN RIA MODULE

K771953 is an FDA 510(k) clearance for GASTRIN RIA MODULE, manufactured by Inter Science Institute. The device is a Class 1 Immunology device with product code CGC cleared through the Traditional 510(k) pathway after a 95-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1978
Decision
95d
Days
Class 1
Risk

K771953 is an FDA 510(k) clearance for the GASTRIN RIA MODULE. Classified as Radioimmunoassay, Gastrin (product code CGC), Class I - General Controls.

Submitted by Inter Science Institute (Mchenry, US). The FDA issued a Cleared decision on January 20, 1978 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1325 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K771953

510(k) Number K771953 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 17, 1977
Decision Date January 20, 1978
Days to Decision 95 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 105d · This submission: 95d
Pathway characteristics
Predicate-based equivalence.

CGC Device Classification - Class 1, General Controls

Product Code CGC Radioimmunoassay, Gastrin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1325
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.